BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15849741)

  • 1. Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice.
    Hu Y; Le Leu RK; Young GP
    Int J Cancer; 2005 Oct; 116(6):870-5. PubMed ID: 15849741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours.
    Hu Y; Le Leu RK; Young GP
    Int J Cancer; 2005 Jul; 115(4):561-7. PubMed ID: 15700305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of sphingomyelin as a chemopreventive agent in AOM-induced colon cancer model: wild-type and p53+/- mice.
    Hu Y; Le Leu RK; Belobrajdic D; Young GP
    Mol Nutr Food Res; 2008 May; 52(5):558-66. PubMed ID: 18324704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
    Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
    Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective acute apoptotic response to genotoxic carcinogen in small intestine of APC(Min/+) mice is restored by sulindac.
    Hu Y; Le Leu RK; Young GP
    Cancer Lett; 2007 Apr; 248(2):234-44. PubMed ID: 16950562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.
    Kuno T; Yamada Y; Hirose Y; Katayama M; Sakata K; Hara A; Saji S; Mori H
    Jpn J Cancer Res; 2002 Mar; 93(3):242-6. PubMed ID: 11927004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers in chemoprevention of colon cancer. Inhibition of expression of ras-p21 and p53 by sulindac during azoxymethane-induced colon carcinogenesis.
    Singh J; Reddy BS
    Ann N Y Acad Sci; 1995 Sep; 768():205-9. PubMed ID: 8526349
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Mutated
    Rice PFS; Ehrichs KG; Jones MS; Chen H; Hsu CH; Abril ER; Nagle RB; Besselsen DG; Barton JK; Ignatenko NA
    Cancer Prev Res (Phila); 2018 Jan; 11(1):16-26. PubMed ID: 29118162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
    Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The colonic response to genotoxic carcinogens in the rat: regulation by dietary fibre.
    Hu Y; Martin J; Le Leu R; Young GP
    Carcinogenesis; 2002 Jul; 23(7):1131-7. PubMed ID: 12117770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.
    Piazza GA; Alberts DS; Hixson LJ; Paranka NS; Li H; Finn T; Bogert C; Guillen JM; Brendel K; Gross PH; Sperl G; Ritchie J; Burt RW; Ellsworth L; Ahnen DJ; Pamukcu R
    Cancer Res; 1997 Jul; 57(14):2909-15. PubMed ID: 9230200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite Instability in Mouse Models of Colorectal Cancer.
    Currey N; Daniel JJ; Mladenova DN; Dahlstrom JE; Kohonen-Corish MRJ
    Can J Gastroenterol Hepatol; 2018; 2018():6152928. PubMed ID: 29686976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-mutagenic lichen extract has double-edged effect on azoxymethane-induced colorectal oncogenesis in C57BL/6J mice.
    He X; Hu Y; Winter J; Young GP
    Toxicol Mech Methods; 2010 Jan; 20(1):31-5. PubMed ID: 20030572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
    Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR
    Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrus auraptene suppresses azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db mice.
    Hayashi K; Suzuki R; Miyamoto S; Shin-Ichiroh Y; Kohno H; Sugie S; Takashima S; Tanaka T
    Nutr Cancer; 2007; 58(1):75-84. PubMed ID: 17571970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPARgamma expression and alteration of lipid composition.
    Kohno H; Yasui Y; Suzuki R; Hosokawa M; Miyashita K; Tanaka T
    Int J Cancer; 2004 Jul; 110(6):896-901. PubMed ID: 15170673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.